December 30, 2010
ROCHE ACQUIRES MARCADIA BIOTECH

December 13, 2010
SEMPRUS BIOSCIENCES LANDS ANOTHER $18M

December 13, 2010
ANAPHORE ENTERS R&D PARTNERSHIP WITH MITSUBISHI TANABE PHARMA TO DEVELOP AND COMMERCIALIZE NOVEL PROTEIN PHARMACEUTICALS FOR AUTOIMMUNE DISORDERS

December 1, 2010
PEARL THERAPEUTICS' PT003 COMBINATION THERAPY FOR COPD DEMONSTRATES SUPERIOR BRONCHODILATION COMPARED TO SPIRIVA® AND FORADIL® IN RANDOMIZED PHASE 2B STUDY

December 1, 2010
GROUND BREAKING DATA ON SYNOSIA'S INVESTIGATIONAL NEW PARKINSON'S DRUG PUBLISHED IN THE JOURNAL OF NEUROSCIENCE

November 30, 2010
IKARIA® BEGINS ENROLLMENT OF PIVOTAL TRIAL FOR LUCASSIN®

November 8, 2010
ANAPHORE ARTICLE IN NATURE BIOTECHNOLOGY 28, 1143 (2010)

October 19, 2010
PEARL THERAPEUTICS RAISES $69 MILLION SERIES C FINANCING

October 14, 2010
RENNOVIA ARTICLE IN SPECIALITY CHEMICALS MAGAZINE, ONLINE EDITION: SAME DIFFERENCE

October 12, 2010
SYNOSIA THERAPEUTICS RAISES $30M IN SERIES C FINANCING

October 12, 2010
UCB AND SYNOSIA THERAPEUTICS SIGN STRATEGIC ALLIANCE IN NEUROLOGY

October 8, 2010
TAKEDA AND ENVOY FORM SCHIZOPHRENIA RESEARCH ALLIANCE

September 29, 2010
SYNOSIA PRESENTS DATA FROM CLINICAL TRIAL OF SYN-118 AS A NEW TREATMENT FOR PARKINSON'S DISEASE

September 28, 2010
RENNOVIA ARTICLE IN ICIS CHEMICAL BUSINESS: BIO-ADIPIC ACID PREPARES FOR ENTRY

September 22, 2010
SEMPRUS BIOSCIENCES AWARDED $500,000 NATIONAL SCIENCE FOUNDATION GRANT

September 20, 2010
RENNOVIA ARTICLE IN C & E NEWS: CATALYZING BIOBASED CHEMICALS

September 15, 2010
POSITIVE PHASE 2 DATA FOR RLY5016 PRESENTED IN LATE-BREAKER SESSION AT HEART FAILURE SOCIETY OF AMERICA MEETING

September 13, 2010
RELYPSA RAISES $70 MILLION IN SERIES B FINANCING

September 9, 2010
ACHAOGEN TO PRESENT NEW DATA ON ACHN-490 AT THE 50TH ANNUAL ICAAC MEETING

August 30, 2010
ACHAOGEN AWARDED CONTRACT WORTH UP TO $64 MILLION BY BARDA FOR THE DEVELOPMENT OF ACHN-490

August 17, 2010
KALOBIOS, SEEKING TO APPLY ANTIBODIES BEYOND CANCER, SETS SIGHT ON KILLING DEADLY LUNG INVADER

August 12, 2010
VIVEVE-SPONSORED RESEARCH TO BE PUBLISHED IN JOURNAL OF SEXUAL MEDICINE

July 15, 2010
IKARIA® NAMES CHIEF SCIENCE OFFICER

July 13, 2010
VIVEVE-SPONSORED RESEARCH ACCEPTED FOR PRESENTATION AT TWO PRESTIGIOUS INTERNATIONAL CONFERENCES

July 8, 2010
IKARIA® NAMES NEW CHIEF FINANCIAL OFFICER

June 28, 2010
MARCADIA AND LILLY SIGN DEVELOPMENT, LICENSE AGREEMENT FOR NOVEL GLUCAGON PROGRAM IN SEVERE HYPOGLYCEMIA

June 22, 2010
INCLINE THERAPEUTICS RAISES $43 MILLION, SIGNS ACQUISITION OPTION

June 15, 2010
WOMEN'S HEALTH COMPANY VIVEVE SPONSORS AWARD WINNING ABSTRACT AT ACOG

June 8, 2010
IKARIA® APPOINTS CHIEF MEDICAL OFFICER

June 5, 2010
SEMPRUS BIOSCIENCES SELECTED AS ONE OF THE "50 COMPANIES TO WATCH" IN MD+DI JUNE ISSUE

June 1, 2010
IKARIA® NAMES NEW HEAD OF RESEARCH & DEVELOPMENT

May 17, 2010
ANTI-PSEUDOMONAS ACTIVITY OF KALOBIOS' / SANOFI PASTEUR'S KB001 MAY PREVENT SERIOUS LUNG INFECTIONS AND LIMIT DAMAGE INFLAMMATION

May 5, 2010
PEARL THERAPEUTICS' BRONCHODILATOR COMBINATION THERAPEUTIC FOR COPD TO BE PRESENTED AT THE AMERICAN THORACIC SOCIETY ANNUAL MEETING

April 14, 2010
SYNOSIA THERAPEUTICS' SYN-115 IMPROVES MOTOR AND NON-MOTOR FUNCTION IN PATIENTS WITH MILD-TO-MODERATE PARKINSON'S DISEASE

April 13, 2010
ENTREMED INITIATES PHASE 2 STUDY FOR ENMD-2076 IN OVARIAN CANCER

April 7, 2010
ACHAOGEN COMPLETES $56 MILLION SERIES C FINANCING

March 30, 2010
IKARIA® ACQUIRES NEW DRUG APPLICATION FOR LUCASSIN®

March 29, 2010
PEARL THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM PHASE 1 TRIAL OF PT003, A BRONCHODILATOR COMBINATION THERAPEUTIC FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND INITIATION OF PHASE 2B TRIAL

February 17, 2010
MARCADIA INITIATES PHASE I CLINICAL TRIAL OF GLP-1/GIP DUAL AGONIST MAR701

February 1, 2010
PEARL THERAPEUTICS RAISES $15 MILLION TO ADVANCE PT003, LAMA/LABA COMBINATION BRONCHODILATOR FOR COPD, INTO PHASE 2B STUDY

February 1, 2010
SYNOSIA ANNOUNCES POSITIVE INTERIM RESULTS FOR POTENTIAL FIRST-IN-CLASS TREATMENT FOR PARKINSON'S DISEASE

January 29, 2010
FLEXION THERAPEUTICS ANNOUNCES AGREEMENTS WITH FOUR MAJOR PHARMACEUTICAL COMPANIES

January 26, 2010
ENVOY ENTERS DIABETES AND OBESITY COLLABORATION WITH MERCK & CO., INC.

January 11, 2010
KALOBIOS PARTNERS WITH SANOFI PASTEUR ON NOVEL PREVENTION AND TREATMENT FOR PSEUDOMONAS AERUGINOSA

January 4, 2010
PEARL THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM PHASE 2A TRIAL OF FORMOTEROL INHALATION AEROSOL IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE